September Events: Regional Conference on Mesothelioma in Philadelphia

The Mesothelioma Applied Research Foundation (Meso Foundation), in collaboration with Penn’s Abramson Cancer Center, announced that on September 26th it will host a regional conference at the Penn's Abramson Cancer Center to bring together area experts in the field of mesothelioma

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Mesothelioma Applied Research Foundation Logo
The conference is open to the public, and specifically aimed at mesothelioma patients, family members, caregivers, healthcare professionals, and those who have been exposed to asbestos.

Alexandria, VA (PRWEB) July 30, 2014

The Mesothelioma Applied Research Foundation (Meso Foundation), in collaboration with the Penn's Abramson Cancer Center, will host a regional conference on September 26, to bring together area experts in the field of mesothelioma. September 26 marks the National Mesothelioma Awareness Day.

The conference is open to the public, and specifically aimed at mesothelioma patients, family members, caregivers, healthcare professionals, and those who have been exposed to asbestos.

The conference will take place on Friday, September 26, 2014 at The HUB, Cira Center at the Penn's Abramson Cancer Center, located at 2929 Arch Street, Philadelphia, PA 19104. To register for the conference, visit OncoLink.org/Conference/Mesothelioma or call 800.789.PENN (7366) and press 2.

The conference is co-chaired by Mary Hesdorffer, CRNP, of the Meso Foundation, Joseph Friedberg, MD, of the Penn's Abramson Cancer Center, and Daniel Sterman, MD, of the Penn's Abramson Cancer Center. Among topics of discussion at the conference will be clinical trial participation, latest advances in peritoneal and pleural mesothelioma, palliative care, early detection, genetics, coping with mesothelioma, and survivorship.

Speakers include:
Mary Hesdorffer, CRNP, Mesothelioma Applied Research Foundation
Joseph Friedberg, MD, Penn's Abramson Cancer Center
Chi Dang, MD, PhD, Penn's Abramson Cancer Center
Julie Brahmer, MD, Johns Hopkins University
Richard Alexander, MD, University of Maryland
Lee Krug, MD, Memorial Sloan Kettering Cancer Center
Andreas Rimner, MD, Memorial Sloan Kettering Cancer Center
Daniel Sterman, MD, Penn's Abramson Cancer Center
Suzanne Walker, CRNP, MSN, AOCN, BC, Penn's Abramson Cancer Center
Anil Vachani, MD, Penn's Abramson Cancer Center
Joseph Testa, PhD, Fox Chase Cancer Center
Eleanor Anderson, MD, Penn's Abramson Cancer Center

Mesothelioma is a malignant tumor of the lining of the lung, abdomen, or heart known to be caused by exposure to asbestos. Medical experts consider it one of the most aggressive and deadly of all cancers. An estimated one-third of those who develop mesothelioma were exposed while serving in the Navy or working in shipyards.

About the Mesothelioma Applied Research Foundation
The Meso Foundation is the only 501(c)(3) nonprofit organization dedicated to eradicating mesothelioma and easing the suffering caused by this cancer. The Meso Foundation actively seeks philanthropic support to fund peer-reviewed mesothelioma research; provide patient support services and education; and advocate Congress for increased federal funding for mesothelioma research. The Meso Foundation is the only non-government funder of peer reviewed scientific research to establish effective treatments for mesothelioma and, ultimately, a cure for this extremely aggressive cancer. To date, the Foundation has awarded over $8.7 million to research. More information is available at http://www.curemeso.org.